You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 24, 2024

List of Excipients in API rezafungin

✉ Email this page to a colleague

« Back to Dashboard

Excipients in NDA-approved (novel) drugs containing rezafungin

Subscribe to access the full database, or Sign Up
Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Melinta Therapeutics LLC	REZZAYO	rezafungin	70842-240	HISTIDINE	2035-03-22
Melinta Therapeutics LLC	REZZAYO	rezafungin	70842-240	HYDROCHLORIC ACID	2035-03-22
Melinta Therapeutics LLC	REZZAYO	rezafungin	70842-240	MANNITOL	2035-03-22
Melinta Therapeutics LLC	REZZAYO	rezafungin	70842-240	POLYSORBATE 80	2035-03-22
Melinta Therapeutics LLC	REZZAYO	rezafungin	70842-240	SODIUM CHLORIDE	2035-03-22
>Company	>Tradename	>Ingredient	>NDC	>Excipient	>Potential Generic Entry

Detailed excipient profiles for rezafungin

Excipient focus: HISTIDINE

rezafungin drug variants containing HISTIDINE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Melinta Therapeutics LLC	rezafungin	70842-240
>Company	>Ingredient	>NDC

rezafungin drug variants not containing HISTIDINE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: HYDROCHLORIC ACID

rezafungin drug variants containing HYDROCHLORIC ACID

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Melinta Therapeutics LLC	rezafungin	70842-240
>Company	>Ingredient	>NDC

rezafungin drug variants not containing HYDROCHLORIC ACID

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: MANNITOL

rezafungin drug variants containing MANNITOL

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Melinta Therapeutics LLC	rezafungin	70842-240
>Company	>Ingredient	>NDC

rezafungin drug variants not containing MANNITOL

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: POLYSORBATE 80

rezafungin drug variants containing POLYSORBATE 80

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Melinta Therapeutics LLC	rezafungin	70842-240
>Company	>Ingredient	>NDC

rezafungin drug variants not containing POLYSORBATE 80

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SODIUM CHLORIDE

rezafungin drug variants containing SODIUM CHLORIDE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Melinta Therapeutics LLC	rezafungin	70842-240
>Company	>Ingredient	>NDC

rezafungin drug variants not containing SODIUM CHLORIDE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.